{"id":978654,"date":"2026-07-06T11:06:09","date_gmt":"2026-07-06T15:06:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/"},"modified":"2026-07-06T11:06:09","modified_gmt":"2026-07-06T15:06:09","slug":"neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/","title":{"rendered":"Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar\u00ae TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.<\/p>\n<p>Neuronetics will participate in a panel discussion titled &#8220;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&#8221; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional investors throughout the day.<\/p>\n<p>This is an in-person, invitation-only event, and there will be no live webcast of the panel discussion.<\/p>\n<p><strong>About\u00a0Neuronetics<\/strong><\/p>\n<p>Neuronetics, Inc. is a leader in interventional mental health, combining innovative treatment technologies with direct patient care. Through its NeuroStar\u00ae Advanced Therapy system, the company is a leading provider of transcranial magnetic stimulation (TMS) treatment and, through Greenbrook, operates one of the largest interventional psychiatry clinic networks in the United States, offering both TMS and SPRAVATO\u00ae therapies. NeuroStar Advanced Therapy is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication has not helped. NeuroStar Advanced Therapy is the leading TMS treatment for MDD in adults and is backed by what we believe is the largest clinical data set of any TMS treatment system for depression. Greenbrook treatment centers also offer SPRAVATO\u00ae (esketamine) Nasal Spray, a prescription medicine indicated for the treatment of treatment-resistant depression (\u201cTRD\u201d) in adults as monotherapy or in conjunction with an oral antidepressant. It is also indicated for depressive symptoms in adults with MDD with acute suicidal ideation or behavior in conjunction with an oral antidepressant.<sup>1<\/sup><\/p>\n<p>The NeuroStar Advanced Therapy System is cleared by the U.S. Food and Drug Administration for adults with MDD, as an adjunct for adults with obsessive-compulsive disorder, to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression), and as a first line adjunct for the treatment of MDD in adolescent patients aged 15-21. For safety information and indications for use, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5yyTadBWYufroaECHRtZEGX9AIzZq1QG7YnjUtBbAR5LaYYXKXGriZK25WZxC_vA6jHVr_QvCHFylAFgKsB8HQ==\" rel=\"nofollow\" target=\"_blank\"><strong>NeuroStar.com<\/strong><\/a>.<\/p>\n<p>Investor Contact:<\/p>\n<p>Mike Vallie or Mark Klausner<br \/>ICR Healthcare<br \/>443-213-0499<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kqsyki6cssuPVvUP-MRuB0fwwyb8tMaoTW8AxJxhakDFkN9ozmNKuTI2cL9vw2goSVqnUmUWiBhVjylN2kL4D5UCnewiGUcYjcCXUfb-rt7Rc-xq0xg0ZVsUczXlQe0_ll0KXk6ASsUFI0xtZ2_SMc7-3zauecvfacDmJvEdAa_WW6_jxqhpF5793w3UHq3awORdTm9IB4L__-KrnwmB47uQIu4hhzJ-IFYFj1Gzpc2LwkTl5s3COqYH80IWWZ9yHblusQS4an3Aqzzg-E1vqg==\" rel=\"nofollow\" target=\"_blank\"><strong><u>ir@neuronetics.com<\/u><\/strong><\/a><\/p>\n<p>Media Contact:<\/p>\n<p>EvolveMKD<br \/>646-517-4220<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5yyTadBWYufroaECHRtZEJFDVEip2ikDmI8qHVUd_ZREr5sQslwQsxSjd2cVf8F3dBxH34uXPkEsQSm6dqtra7c6fDI-5SDb2NabK9wAqVo=\" rel=\"nofollow\" target=\"_blank\"><strong>NeuroStar@evolvemkd.com<\/strong><\/a><\/p>\n<p>\n        <strong>References<\/strong><br \/>\n        <br \/>\n        <sup>1<\/sup>\u00a0The effectiveness of SPRAVATO\u00ae\u00a0in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. Use of SPRAVATO\u00ae\u00a0does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of SPRAVATO\u00ae. For more important safety information about SPRAVATO\u00ae, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HqhDK8s6q2fwnAuzhZLkiYzpBD4HZV768DH4LTvryGTMDCqw2kd0NGs49KsQsW5l74KOn92VFO4S1FIbNzxFsC0RwQgGfRlQW3qolD2-qkk=\" rel=\"nofollow\" target=\"_blank\"><strong>spravatohcp.com<\/strong><\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDQ2OWU5NzktNDZlMC00YjQ3LTk0MzQtZjIyYzFlZGMyMTlkLTExMjIwMTEtMjAyNi0wNy0wNi1lbg==\/tiny\/Neuronetics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar\u00ae TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston. Neuronetics will participate in a panel discussion titled &#8220;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&#8221; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional investors throughout the day. This is an in-person, invitation-only event, and there will be no live webcast of the panel discussion. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-978654","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#039; Mind, Muscle &amp; Vision Summit on July 16, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#039; Mind, Muscle &amp; Vision Summit on July 16, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar\u00ae TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston. Neuronetics will participate in a panel discussion titled &#8220;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&#8221; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional investors throughout the day. This is an in-person, invitation-only event, and there will be no live webcast of the panel discussion. &hellip; Continue reading &quot;Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-06T15:06:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026\",\"datePublished\":\"2026-07-06T15:06:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/\"},\"wordCount\":451,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/\",\"name\":\"Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle &amp; Vision Summit on July 16, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=\",\"datePublished\":\"2026-07-06T15:06:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle &amp; Vision Summit on July 16, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/","og_locale":"en_US","og_type":"article","og_title":"Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle &amp; Vision Summit on July 16, 2026 - Market Newsdesk","og_description":"MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) &#8212; Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar\u00ae TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston. Neuronetics will participate in a panel discussion titled &#8220;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&#8221; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional investors throughout the day. This is an in-person, invitation-only event, and there will be no live webcast of the panel discussion. &hellip; Continue reading \"Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-06T15:06:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026","datePublished":"2026-07-06T15:06:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/"},"wordCount":451,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/","name":"Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle &amp; Vision Summit on July 16, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=","datePublished":"2026-07-06T15:06:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Njg5NiM3NjkwNTEyIzIxMTA0NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Neuronetics to Participate in a Panel Discussion at B. Riley Securities&#8217; Mind, Muscle &amp; Vision Summit on July 16, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/978654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=978654"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/978654\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=978654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=978654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=978654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}